CARCINOMA, SMALL CELL LUNG
Clinical trials for CARCINOMA, SMALL CELL LUNG explained in plain language.
Never miss a new study
Get alerted when new CARCINOMA, SMALL CELL LUNG trials appear
Sign up with your email to follow new studies for CARCINOMA, SMALL CELL LUNG, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare lung cancer: experimental drug combo enters human trials
Disease control Recruiting nowThis study tests a new medicine called PF-08634404 given with chemotherapy for adults with transformed small cell lung cancer (T-SCLC), a rare and aggressive cancer that develops from another lung cancer type. About 40 participants will receive the drug combo through IV infusions…
Matched conditions: CARCINOMA, SMALL CELL LUNG
Phase: PHASE2 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New hope for lung cancer patients: maintenance drug aims to keep disease at bay
Disease control Recruiting nowThis study tests a drug called tarlatamab as a maintenance treatment for people with limited-stage small cell lung cancer who cannot receive standard combined chemotherapy and radiation. After completing chemotherapy with or without radiation, participants who have not gotten wor…
Matched conditions: CARCINOMA, SMALL CELL LUNG
Phase: PHASE2 • Sponsor: Fundación GECP • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC